Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Doxil +/- Dexamethasone in Metastatic Hormone Refractory Prostate Cancer
NCT00176293Phase 2Terminated
- Sponsor
- University of Kentucky
- Start
- Oct 2005
- Primary completion
- Feb 2007
- Modality
- Targeted Liposomes, Stealth (PEGylated) Liposomes, Conventional Liposomes
- Countries
- 1
01
Overview
A Phase 2 trial of pegylated liposomal doxorubicin in prostate cancer (PCa), sponsored by University of Kentucky. Started Oct 2005; status: terminated.
02
Drugs
pegylated liposomal doxorubicin
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00176293.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00176293.